evaluating the addition of venetoclax to a chemotherapy backbone in pediatric aml patients
Published 1 year ago • 62 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
3:52
venetoclax & aml
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
12:05
venetoclax combinations, safety and efficacy
-
2:30
real-world outcomes of venetoclax azacitidine versus intensive chemotherapy in newly diagnosed aml
-
4:52
apoptosis and venetoclax
-
2:25
venetoclax for aml
-
2:43
venetoclax and intensive chemotherapy in npm1-mutated aml: findings from the caveat study
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
4:38
novel combinations being explored in aml using an hma-venetoclax backbone
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
4:20
updates from a study evaluating astx727 venetoclax for patients with aml
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:08
the importance of predicting venetoclax response in patients with aml
-
2:46
combination approaches in aml and overcoming venetoclax resistance
-
1:56
clinical trials investigating venetoclax combinations for aml
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
2:49
improving the activity of bh3 mimetic venetoclax: a case study
-
1:07
preliminary promise for venetoclax and 3 7 in untreated aml